End-of-day quote
Taiwan S.E.
18:00:00 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
23.9
TWD
|
0.00%
|
|
0.00%
|
-3.24%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,374
|
2,214
|
1,925
|
2,103
|
2,047
|
2,137
|
Enterprise Value (EV)
1 |
1,447
|
1,721
|
1,495
|
1,714
|
1,681
|
1,867
|
P/E ratio
|
15.1
x
|
38.9
x
|
32.3
x
|
18.7
x
|
35.9
x
|
65
x
|
Yield
|
5.62%
|
3.21%
|
3.14%
|
4.52%
|
2.95%
|
-
|
Capitalization / Revenue
|
5.84
x
|
6.4
x
|
5.92
x
|
4.91
x
|
5.55
x
|
6.72
x
|
EV / Revenue
|
3.56
x
|
4.97
x
|
4.6
x
|
4.01
x
|
4.56
x
|
5.87
x
|
EV / EBITDA
|
9.76
x
|
18
x
|
16.8
x
|
12
x
|
15.3
x
|
27.1
x
|
EV / FCF
|
-6.22
x
|
-5.74
x
|
-35.9
x
|
-709
x
|
21.4
x
|
-1,188
x
|
FCF Yield
|
-16.1%
|
-17.4%
|
-2.78%
|
-0.14%
|
4.68%
|
-0.08%
|
Price to Book
|
1.59
x
|
1.6
x
|
1.45
x
|
1.53
x
|
1.51
x
|
1.62
x
|
Nbr of stocks (in thousands)
|
88,912
|
88,934
|
86,341
|
86,371
|
86,371
|
86,511
|
Reference price
2 |
26.70
|
24.90
|
22.30
|
24.35
|
23.70
|
24.70
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/24/21
|
3/23/22
|
3/15/23
|
3/12/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
406.5
|
346.2
|
325.2
|
427.9
|
368.5
|
318
|
EBITDA
1 |
148.3
|
95.69
|
88.77
|
143.1
|
109.9
|
68.77
|
EBIT
1 |
122.2
|
77.61
|
70.97
|
125
|
61.97
|
6.988
|
Operating Margin
|
30.05%
|
22.41%
|
21.82%
|
29.22%
|
16.81%
|
2.2%
|
Earnings before Tax (EBT)
1 |
123.9
|
75.54
|
76.85
|
139.4
|
66.26
|
28.16
|
Net income
1 |
158
|
57.45
|
60.88
|
113.1
|
56.98
|
32.99
|
Net margin
|
38.87%
|
16.59%
|
18.72%
|
26.44%
|
15.46%
|
10.37%
|
EPS
2 |
1.766
|
0.6400
|
0.6900
|
1.300
|
0.6597
|
0.3800
|
Free Cash Flow
1 |
-232.7
|
-299.6
|
-41.58
|
-2.417
|
78.65
|
-1.572
|
FCF margin
|
-57.23%
|
-86.53%
|
-12.79%
|
-0.56%
|
21.34%
|
-0.49%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
71.56%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
138.04%
|
-
|
Dividend per Share
2 |
1.500
|
0.8000
|
0.6998
|
1.100
|
0.7000
|
-
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/24/21
|
3/23/22
|
3/15/23
|
3/12/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
927
|
494
|
431
|
389
|
366
|
270
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-233
|
-300
|
-41.6
|
-2.42
|
78.7
|
-1.57
|
ROE (net income / shareholders' equity)
|
6.69%
|
3.8%
|
4.11%
|
7.29%
|
3.14%
|
1.52%
|
ROA (Net income/ Total Assets)
|
4.84%
|
3%
|
2.79%
|
4.72%
|
2.28%
|
0.26%
|
Assets
1 |
3,268
|
1,913
|
2,185
|
2,397
|
2,496
|
12,650
|
Book Value Per Share
2 |
16.80
|
15.60
|
15.40
|
15.90
|
15.60
|
15.20
|
Cash Flow per Share
2 |
2.530
|
2.160
|
3.180
|
1.970
|
1.550
|
0.6400
|
Capex
1 |
275
|
394
|
139
|
117
|
71.2
|
33.3
|
Capex / Sales
|
67.67%
|
113.71%
|
42.67%
|
27.33%
|
19.32%
|
10.47%
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/24/21
|
3/23/22
|
3/15/23
|
3/12/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.24% | 63.65M | | +13.21% | 8.12B | | +4.64% | 7.45B | | -17.32% | 4.88B | | -8.76% | 3.62B | | -20.43% | 3.17B | | -11.51% | 1.21B | | -31.91% | 1.04B | | -15.60% | 862M | | -8.57% | 879M |
Special Foods & Wellbeing Products
|